[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE385900B - N-isobornyloxikarbonylcefalosporin c som mellanprodukt for utvinning av cefalosporin c - Google Patents

N-isobornyloxikarbonylcefalosporin c som mellanprodukt for utvinning av cefalosporin c

Info

Publication number
SE385900B
SE385900B SE7202370A SE237072A SE385900B SE 385900 B SE385900 B SE 385900B SE 7202370 A SE7202370 A SE 7202370A SE 237072 A SE237072 A SE 237072A SE 385900 B SE385900 B SE 385900B
Authority
SE
Sweden
Prior art keywords
isobornyloxicarbonylcephalosporin
cefalosporin
intermediate product
product
Prior art date
Application number
SE7202370A
Other languages
English (en)
Inventor
S Horii
N Mizokami
M Fujino
S Shinagawa
M Ochiai
T Okutani
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1006371A external-priority patent/JPS514997B1/ja
Priority claimed from JP6241771A external-priority patent/JPS5121998B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE385900B publication Critical patent/SE385900B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/12Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
SE7202370A 1971-02-26 1972-02-25 N-isobornyloxikarbonylcefalosporin c som mellanprodukt for utvinning av cefalosporin c SE385900B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1013771 1971-02-26
JP1006371A JPS514997B1 (sv) 1971-02-26 1971-02-26
JP6241771A JPS5121998B2 (sv) 1971-08-17 1971-08-17

Publications (1)

Publication Number Publication Date
SE385900B true SE385900B (sv) 1976-07-26

Family

ID=27278818

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7202370A SE385900B (sv) 1971-02-26 1972-02-25 N-isobornyloxikarbonylcefalosporin c som mellanprodukt for utvinning av cefalosporin c

Country Status (11)

Country Link
US (1) US3819619A (sv)
BE (1) BE779889A (sv)
CA (1) CA982554A (sv)
CH (1) CH567037A5 (sv)
DE (1) DE2208631C3 (sv)
FR (1) FR2126450B1 (sv)
GB (1) GB1359092A (sv)
HU (1) HU166159B (sv)
IE (1) IE36089B1 (sv)
NL (1) NL7202472A (sv)
SE (1) SE385900B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283492A (en) * 1975-06-21 1981-08-11 Fujisawa Pharmaceutical Co., Ltd. Production of antibiotics WS-3442 A, B, C, D and E, and their acyl derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL139980B (nl) * 1961-07-25 1973-10-15 Ciba Geigy Werkwijze ter bereiding van therapeutisch werkzame derivaten van cefalosporine c en van farmaceutische preparaten die deze derivaten bevatten.
FR1544577A (fr) * 1966-12-05 1968-10-31 Ciba Geigy Procédé pour isoler la céphalosporine c.

Also Published As

Publication number Publication date
DE2208631C3 (de) 1978-05-03
CH567037A5 (sv) 1975-09-30
IE36089B1 (en) 1976-08-18
FR2126450B1 (sv) 1975-06-13
CA982554A (en) 1976-01-27
US3819619A (en) 1974-06-25
BE779889A (fr) 1972-06-16
HU166159B (sv) 1975-01-28
DE2208631B2 (de) 1977-08-25
DE2208631A1 (de) 1972-08-31
NL7202472A (sv) 1972-08-29
FR2126450A1 (sv) 1972-10-06
IE36089L (en) 1973-08-26
GB1359092A (en) 1974-07-10

Similar Documents

Publication Publication Date Title
SE390414B (sv) 14,15-dioxo-e-homo-eburnaner som mellanprodukt for framstellning av vinkamin
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE394373B (sv) Forfarande for destillering av vetskor
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE386672B (sv) Mellanprodukter for framstellning av isokinolinderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE386678B (sv) Forfarande for framstellning av fluoranderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE415837B (sv) Forfarande for framstellning av 15-ketaler av prostaglandiner
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE7602150L (sv) Mellanprodukter for framstellning av 4a-aryl-trans-dekahydroisokinolin
SE385482B (sv) Forfarande for framstellning av basiskt substituerade 3-bensoyl-benso(b)tiofen-derivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE7601707L (sv) Mellanprodukt for framstellning av substituerade 3-amino-prop-1-ener
SE7508078L (sv) Forfarande for framstellning av prostaglandinanaloger.
SE385900B (sv) N-isobornyloxikarbonylcefalosporin c som mellanprodukt for utvinning av cefalosporin c
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat